Federally Qualified Health Centers (FQHC) participating in the 340B Drug Pricing Program are subject to the annual recertification process which began January 25, 2017. Any entities that have not successfully recertified by the February 22, 2017 closing date will be terminated from the program.
Information outlining the recertification process was sent directly from HRSA on January 25 via the official HRSA email address, email@example.com. Recertification is directly contingent upon the Authorizing Official’s receipt of the Username and Password from HRSA to begin the process. If a covered entity needs to verify which email address received the login information, they can contact Apexus.
Resources are available to help guide health centers through the recertification process. User guides can be found on the OPA database at http://www.hrsa.gov/opa/. To recertify, health centers will want to coordinate with their compliance, administration and finance teams, and also refer to the HRSA Electronic Handbook.
Questions regarding recertification should be directed to Apexus Answers via email at firstname.lastname@example.org or by phone (1-888-340-2787), though we welcome you to contact us if you have questions or concerns via email (email@example.com ) or phone (1-855-835-340B).